Status:
COMPLETED
A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss, Bilateral or Unilateral
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
Hearing impaired participants will be fit with study devices which will have three different hearing aid programs. Speech intelligibility will be measured using validated tests for each of the three h...
Detailed Description
Program 1 is the current default in the commercially available devices. Programs 2 and 3 are being tested against the current default.
Eligibility Criteria
Inclusion
- Bilateral moderate to severe hearing loss (N3-N4)
- Experienced hearing aid user
- Fluent in English
- Cognitively able to complete complex listening tasks
Exclusion
- Unilateral hearing loss
- New hearing aid user
- Unable or unwilling to complete complex listening tasks
Key Trial Info
Start Date :
April 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06957730
Start Date
April 22 2025
End Date
May 1 2025
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phonak Audiology Research Center
Aurora, Illinois, United States, 60504